Effects of dietary fat profile on gut permeability and microbiota and their relationships with metabolic changes in mice

Obesity

Volumn 23, Issue 7, 2015, Pages 1429-1439

  Lam, Yan Y ^a,b   Ha, Connie W Y ^a   Hoffmann, Jenny M A ^a,c   Oscarsson, Jan ^d   Dinudom, Anuwat ^a   Mather, Thomas J ^a   Cook, David I ^a   Hunt, Nicholas H ^a   Caterson, Ian D ^a   Holmes, Andrew J ^a   Storlien, Len H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID DERIVATIVE; FISH OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; RESOLVIN D1; UNCLASSIFIED DRUG; FAT INTAKE; FATTY ACID;

ACETIVIBRIO; AKKERMANSIA; ALLOBACULUM; ANAEROTRUNCUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; BACTEROIDES; BACTEROIDETES; BAMESIELLA; BIFIDOBACTERIUM; BILOPHILA; CLOSTRIDIUM SENSU STRICTO; CLOSTRIDIUM XI; COLITIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; ERYSIPELOTRICHACEAE; FAT INTAKE; FEMALE; FIRMICUTES; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LACHNOSPIRACEAE; LACTOBACILLUS; LIPID DIET; LOW DRUG DOSE; MESENTERY; METABOLIC DISORDER; MOUSE; MUCISPIRILLUM; NONHUMAN; OSCILLIBACTER; POPULATION ABUNDANCE; PSEUDOFLAVONIFRACTOR; RUMINOCOCCACEAE; TURICIBACTER; VERRUCOMICROBIA; WEIGHT CHANGE; WEIGHT GAIN; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; INFLAMMATION; INTESTINE; METABOLISM; MICROBIOLOGY; OBESITY; PERMEABILITY;

MUS;

ANIMALS; DIET, HIGH-FAT; DIETARY FATS; FATTY ACIDS; GASTROINTESTINAL MICROBIOME; INFLAMMATION; INTESTINES; MICE; MICE, INBRED C57BL; OBESITY; PERMEABILITY; WEIGHT GAIN;

EID: 84932648961     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21122     Document Type: Article

References (40)

1. Schwab U, Lauritzen L, Tholstrup T, et al., Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review. Food Nutr Res 2014; 58.
2. Everard A, Cani PD,. Diabetes, obesity and gut microbiota. Best Practice Res Clin Gastroenterol 2013; 27: 73-83.
3. Lam YY, Ha CW, Campbell CR, et al., Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 2012; 7: e34233.
4. Cani PD, Bibiloni R, Knauf C, et al., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008; 57: 1470-1481.
5. Backhed F, Manchester JK, Semenkovich CF, et al., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007; 104: 979-984.
6. Rabot S, Membrez M, Bruneau A, et al., Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism. FASEB J 2010; 24: 4948-4959.
7. Wang B, Gong X, Wan JY, et al., Resolvin d1 protects mice from LPS-induced acute lung injury. Pulmonary Pharmacol Therap 2011; 24: 434-441.
8. Hellmann J, Tang Y, Kosuri M, et al., Resolvin d1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J 2011; 25: 2399-2407.
9. Brun P, Castagliuolo I, Di Leo V, et al., Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G525.
10. Nubel U, Engelen B, Felske A, et al., Sequence heterogeneities of genes encoding 16S rRNAs in Paenibacillus polymyxa detected by temperature gradient gel electrophoresis. J Bacteriol 1996; 178: 5636-5643.
11. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
12. Mitchell AJ, Pradel LC, Chasson L, et al., Technical advance: autofluorescence as a tool for myeloid cell analysis. J Leukoc Biol 2010; 88: 597-603.
13. Amar J, Chabo C, Waget A, et al., Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559-572.
14. Devkota S, Wang Y, Musch MW, et al., Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012; 487: 104-108.
15. Serhan CN, Chiang N, Van Dyke TE,. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8: 349-361.
16. Suzuki T,. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci 2013; 70: 631-659.
17. Murphy EF, Cotter PD, Healy S, et al., Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010; 59: 1635-1642.
18. Lam YY, Mitchell AJ, Holmes AJ, et al., Role of the gut in visceral fat inflammation and metabolic disorders. Obesity (Silver Spring) 2011; 19: 2113-2120.
19. Leber B, Tripolt NJ, Blattl D, et al., The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. Eur J Clin Nutr 2012; 66: 1110-1115.
20. Gummesson A, Carlsson LM, Storlien LH, et al., Intestinal permeability is associated with visceral adiposity in healthy women. Obesity (Silver Spring) 2011; 19: 2280-2282.
21. Cenac N, Coelho AM, Nguyen C, et al., Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 2002; 161: 1903-1915.
22. Suzuki T, Hara H,. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 2010; 7: 19.
23. Stenman LK, Holma R, Gylling H, et al., Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity. Br J Nutr 2013; 110: 1157-1164.
24. Yu CG, Huang Q,. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease. J Digest Dis 2013; 14: 513-517.
25. Hulin SJ, Singh S, Chapman MA, et al., Sulfide-induced energy deficiency in colonic cells is prevented by glucose but not by butyrate. Aliment Pharmacol Ther 2002; 16: 325-331.
26. De Fazio L, Cavazza E, Spisni E, et al., Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice. World J Gastroenterol 2014; 20: 2051-2061.
27. Loubinoux J, Bronowicki JP, Pereira IA, et al., Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol Ecol 2002; 40: 107-112.
28. Den Hond E, Hiele M, Evenepoel P, et al., In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998; 115: 584-590.
29. Camuesco D, Galvez J, Nieto A, et al., Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr 2005; 135: 687-694.
30. Calder PC,. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008; 52: 885-897.
31. Watts T, Berti I, Sapone A, et al., Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci USA 2005; 102: 2916-2921.
32. Bendet N, Scapa E, Cohen O, et al., Enhanced glucose-dependent glucagon-like peptide-1 and insulin secretion in crohn patients with terminal ileum disease is unrelated to disease activity or ileal resection. Scand J Gastroenterol 2004; 39: 650-656.
33. Bertin B, Desreumaux P, Dubuquoy L,. Obesity, visceral fat and Crohn's disease. Curr Opin Clin Nutr Metab Care 2010; 13: 574-580.
34. Bregenzer N, Hartmann A, Strauch U, et al., Increased insulin resistance and beta cell activity in patients with Crohn's disease. Inflamm Bowel Dis 2006; 12: 53-56.
35. Valentini L, Ramminger S, Haas V, et al., Small intestinal permeability in older adults. Physiol Rep 2014; 2: e00281.
36. Ha CW, Lam YY, Holmes AJ,. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health. World J Gastroenterol 2014; 20: 16498-16517.
37. Laugerette F, Furet JP, Debard C, et al., Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Am J Physiol Endocrinol Metab 2012; 302: E374-E386.
38. Laugerette F, Vors C, Peretti N, et al., Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie 2011; 93: 39-45.
39. Maukonen J, Saarela M,. Human gut microbiota: does diet matter? Proc Nutr Soc 2015; 74: 23-36.
40. Ferreyra JA, Ng KM, Sonnenburg JL,. The enteric two-step: nutritional strategies of bacterial pathogens within the gut. Cell Microbiol 2014; 16: 993-1003.